Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WAP four-disulfide core domain protein 5 (WFDC5) is a member of the WAP (whey acidic protein) type four-disulfide core (WFDC) domain protein family, characterized by the presence of a conserved 40–50 amino acid sequence containing eight cysteines that form four disulfide bonds at the protein core[1][3]. WFDC5 is unique among many in its family for having two WFDC domains, which are structural motifs that typically confer protease inhibitor activity[1]. These proteins are extracellular modulators and may play roles in host defense mechanisms, such as protease inhibition and possible modulation of immune responses[1][3]. The expression of WFDC5 has been found predominantly in skin, but its precise physiological and pathological roles remain largely uncharacterized, and it is currently not considered a well-established therapeutic target[1][3]. There are no drugs known to specifically target WFDC5, and its involvement in disease or its potential as a biomarker or as a safety concern has not been substantiated in available research[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WAP four-disulfide core domain protein 5 (WFDC5).